Health Highlights: Dec. 14, 2022

New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read more
Move to electric cars will save lives and billions in health care costs. Replacing vehicles powered by gas and diesel with electric ones will pay big dividends for Americans' health, a new study finds. Read more
Big U.S. genetics study is already helping participants. Called "All of Us," the study aims to eventually include at least 1 million people, in an effort to accelerate medical breakthroughs. Read more
Long COVID has taken the lives of more than 3,500 Americans. Research is revealing that the damage caused by a COVID infection poses a long-term risk to some who survive their bout with the coronavirus. Read more
Related Posts
Most Kids Newly Diagnosed With ADHD Aren’t Getting Best Care
TUESDAY, Oct. 19, 2021 (HealthDay News) -- Preschoolers with attention deficit...
Upper Airway Stimulation Effective in Teens With Down Syndrome, OSA
THURSDAY, April 21, 2022 (HealthDay News) -- For adolescents with Down syndrome...
More Than Half of People Infected With Omicron Variant Were Unaware
WEDNESDAY, Aug. 24, 2022 (HealthDay News) -- More than half of adults with a...
AHA News: ¿La amabilidad equivale a la felicidad y la salud?
MARTES, 15 de febrero de 2022 (American Heart Association News) -- ¿Podría ser...